A systematic assessment via the American Academy of Neurology examined publications from 1948 by way of November 2013 concerning the use of cannabinoids during the treatment method of multiple sclerosis, movement disorders, and epilepsy.fifty eight Only oral cannabis extracts (combined THC/CBD or CBD alone) experienced a adequate degree of evidence